Skip to main content

stock

TMDX · TransMedics Group, Inc.

What TransMedics Group, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live TMDX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on TMDX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
34,675,145 as of 2026-07-30 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
58.7%
Operating
12.2%
Net
22.7%

Returns

ROE
29.3%
ROA
10.4%

Health

Current ratio
6.6x
Debt/equity
—

Deep value

NCAV
-$295.22M
NCAV per share
-$8.51
Price/NCAV
Locked
NNWC
-$350.06M
NNWC per share
-$10.10
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$189.95M$113.20M$23.74M$14.68M
10-Q filed 2026-08-04
2026-03-31$173.93M$101.16M$13.30M$7.32M
10-Q filed 2026-08-04
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$160.76M$93.41M$21.27M$105.39M
DEF 14A filed 2026-04-10
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$143.82M$84.58M$23.30M$24.32M
10-Q filed 2025-10-29
2025-06-30$157.37M$96.59M$36.57M$34.91M
10-Q filed 2026-08-04
2025-03-31$143.54M$88.23M$27.44M$25.68M
10-Q filed 2026-08-04
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$121.62M$72.01M$8.64M$6.89M
DEF 14A filed 2026-04-10
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$108.76M$60.84M$3.92M$4.22M
10-Q filed 2025-10-29
Assets
$1.46B
Equity
$518.05M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$605.49M$108.58M$190.30M$133.59M
2024-12-31$441.54M$37.50M$35.50M-$80.94M
2023-12-31$241.62M-$28.73M-$25.00M-$164.88M
2022-12-31$93.46M-$31.44M-$36.20M-$57.72M
2021-12-31$31.39M-$39.43M-$44.20M-$32.38M
2020-12-31$28.36M-$26.38M-$28.75M-$30.72M
2019-12-28$25.84M-$29.60M-$33.55M-$32.45M
2018-12-29$14.66M-$20.24M-$23.76M-$26.40M

Company filings

events

  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Sep 108-K
  • Results

    Results
    Aug 48-K
  • Shareholder vote results

    Shareholder vote results
    May 218-K
  • Results

    Results
    May 58-K
  • Results

    Results
    Feb 278-K
  • Results

    Results
    Feb 248-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named TMDX, and the market events around them.

Sign in to see this

Board

The TMDX board could not be loaded.

Retry the TMDX board

nakagai

Signals on TMDX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the TMDX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

TransMedics Group, Inc. (TMDX): SEC filings, financials and insider trades · Nakagai